Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
Hopen Life Science Ventures
AddedFeb 15, 2024
UpdatedJun 28, 2026
Hopen Life Science Ventures

Hopen Life Science Ventures

Operating

Hopen Therapeutics: A venture capital firm specializing in funding and guiding early-stage life science developments.

Location
Grand Rapids, MI, US
Founded
2008
Firm
Compare
Portfolio
Employees
Website

Hopen Life Science Ventures focuses on early- to mid-stage life science opportunities, with a particular emphasis on the Midwest region. The firm invests in healthcare and pharmaceutical concepts, typically participating in Series A to Series D funding rounds. Their investment strategy targets promising developments in the life sciences sector.

The firm's team comprises professionals with extensive senior leadership experience in public and private life science companies. Notable portfolio companies include Delphinus Medical Technologies, Cirius Therapeutics, and Metabolic Solutions Development. Hopen Life Science Ventures offers portfolio companies expertise, industry relationships, and capital to help them achieve commercial success.

Hopen Life Science Ventures - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments10
Current Portfolio Count8
Total Portfolio Exits0

Top Investment Stages

Series A2 (22.2%)
Series B2 (22.2%)
Series C2 (22.2%)
Series D2 (22.2%)
Grant1 (11.1%)

Stage Mix

Series A 22%Series B 22%Series C 22%Series D 22%Grant 11%

Concentration shown as share of disclosed investments by stage.

Recent Investments

Delphinus Medical Technologies logo

Delphinus Medical Technologies

Cirius Therapeutics logo

Cirius Therapeutics

NeoChord logo

NeoChord

Prevacept Infection Control logo

Prevacept Infection Control

Bjond logo

Bjond

Tolera Therapeutics logo

Tolera Therapeutics

Metabolic Solutions Development logo

Metabolic Solutions Development

Nymirum logo

Nymirum

Hopen Life Science Ventures - Similar Investment Firms

Healthcare Ventures logo

Healthcare Ventures

hcven.com

LifeSci Venture Partners logo

LifeSci Venture Partners

lifesciventure.com

30Ventures logo

30Ventures

Nan Fung Life Sciences logo

Nan Fung Life Sciences

LSP Bioventures logo

LSP Bioventures

lspvc.com

Agilent Ventures logo

Agilent Ventures

Venture Investors logo

Venture Investors

Helicase Venture logo

Helicase Venture

Hunt Ventures logo

Hunt Ventures

Altitude Life Science Ventures logo

Altitude Life Science Ventures

altitudelsv.com

Mirae Asset Capital Life Science logo

Mirae Asset Capital Life Science

Life Science Angels logo

Life Science Angels

Bioventures Investors logo

Bioventures Investors

MedScience Ventures logo

MedScience Ventures

HC9 Ventures logo

HC9 Ventures

hc9.vc

Hopen Life Science Ventures - Classification

NAICS
  • 520000Finance and Insurance
SIC
  • 6000Depository Institutions